Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-25

Clinical Trial Update: Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING) [Phase 4]

View source ↗

Summary

A Phase 4 trial from Ohio State University evaluated how different dosing regimens of ketorolac affect post-cesarean pain management, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toradol (ketorolac tromethamine)

Snippet

Sponsor: Ohio State University | Conditions: Post Cesarean Pain | Phase 4 | Status: COMPLETED | Results posted: 2026-02-25